Previous 10 | Next 10 |
MALVERN, Pa., April 02, 2020 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today an...
The following slide deck was published by Galera Therapeutics, Inc. in conjunction with this Read more ...
Galera Therapeutics (NASDAQ: GRTX ): Q4 GAAP EPS of -$1.31 misses by $0.74 . More news on: Galera Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
- Expanded Lead Product Candidate Avasopasem Manganese into Second Radiation Toxicity Indication - - Presented Data Demonstrating Avasopasem Manganese Maintained Anti-Cancer Benefit of Chemoradiotherapy for Head and Neck Cancer While Substantially Reducing Radiation-Induced Severe Ora...
MALVERN, Pa., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today ann...
MALVERN, Pa., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today ann...
MALVERN, Pa., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today ann...
-- Evaluates avasopasem manganese’s ability to reduce the incidence of radiation-induced esophagitis in patients with lung cancer -- -- Marks expansion of lead product candidate avasopasem manganese into second radiation toxicity indication -- MALVERN, Pa., Jan. 07, 2020 (GL...
Gainers: Inpixon (NASDAQ: INPX ) +68% . More news on: Inpixon, Mirum Pharmaceuticals, Inc., YayYo, Inc., Stocks on the move, Read more ...
Galera Therapeutics (NASDAQ: GRTX ): Q3 EPS of -$51.43 may not be comparable to consensus of -$0.47. More news on: Galera Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Galera Therapeutics Inc. Company Name:
GRTX Stock Symbol:
NYSE Market:
Galera Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Nauticus Robotics Inc. (KITT) rose 29.5% to $0.1787 on volume of 92,016,620 shares Freight Technologies Inc. (FRGT) rose 92.0% to $1.2 on volume of 65,878,105 shares Aethlon Medical Inc. (AEMD) rose 68.2% to $0.7379 on volume of 48,98...
A look at the top 10 most actives in the United States ENDRA Life Sciences Inc. (NDRA) rose 88.2% to $0.159999 on volume of 216,555,450 shares Crown Electrokinetics Corp. (CRKN) fell 13.1% to $0.0908 on volume of 52,298,971 shares Actelis Networks Inc (ASNS) rose 591.5% to $3.25 on volume...
A look at the top 10 most actives in the United States SOBR Safe Inc. (SOBR) rose 74.6% to $0.46 on volume of 265,324,361 shares MicroAlgo Inc. (MLGO) rose 669.9% to $12.01 on volume of 183,977,846 shares PROSHARES TRUST (SQQQ) fell 0.7% to $9.86 on volume of 124,114,596 shares Faraday ...